kanamycin a has been researched along with Hearing Loss in 72 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 31 (43.06) | 18.7374 |
1990's | 4 (5.56) | 18.2507 |
2000's | 7 (9.72) | 29.6817 |
2010's | 22 (30.56) | 24.3611 |
2020's | 8 (11.11) | 2.80 |
Authors | Studies |
---|---|
Jeon, J; Kim, SY; Lee, CH; Lee, SM | 1 |
Chen, Z; Dong, H; Fang, J; Mao, S; Shi, H; Su, K; Wu, H; Xing, Y; Yu, D; Zhang, J | 1 |
Chen, M; Ke, Z; Li, M; Li, Y; Liu, K; Qiao, Y; Shi, X; Wang, Y; Wu, L; Zheng, L | 1 |
Balkissou Adamou, D; Kuaban, C; Pefura-Yone, EW; Poka-Mayap, V | 1 |
Budhathoki, C; Dooley, KE; Dowdy, DW; Farley, JE; Francis, HW; Han, HR; Hong, H | 1 |
Deng, X; Hu, Z | 1 |
Bo, C; Han, Y; Liang, S; Liu, W; Wang, H; Wang, M; Wang, X; Xu, L; Zhang, D; Zhang, Z | 1 |
Dai, X; He, XL; Huang, S; Li, J; Xia, ZF; Xiao, H; Yang, R; Zhang, Y | 1 |
Bermúdez-Muñoz, JM; García-Alcántara, F; Martínez-Vega, R; Milo, M; Murillo-Cuesta, S; Pulido, S; Rivera, T; Varela-Nieto, I | 1 |
Ahmed, S; Akhanda, MW; Banu, S; Ebers, A; Gleason, AT; Heysell, SK; Houpt, ER; Rahman, MT | 1 |
Jung, G; Kim, SY; Koo, JW; Shim, YJ | 1 |
Qiu, J; Qiu, Y; Song, Y; Sun, F; Tian, K; Wang, R; Yue, B; Zha, D; Zhou, K | 1 |
Takasu, K; Tateno, T | 1 |
Deng, X; Hu, Z; Li, X; Liu, Z; Zhou, Y | 1 |
Gao, J; Guo, WW; Han, DY; Li, Z; Sun, AL; Sun, DX; Sun, JH; Wei, XN; Yang, SM; Zhang, XF | 1 |
Bharti, H; Bhushan, B; Chander, R; Gupta, A; Kajal, NC; Ranga, V | 1 |
Abbas, L; Rivolta, MN | 1 |
Leufkens, HG; Mantel-Teeuwisse, AK; Mavhunga, F; Rennie, T; Ruswa, N; Sagwa, EL | 1 |
Chabot, N; Clemo, HR; Corley, SB; Lomber, SG; Meredith, MA | 1 |
Basta, D; Ernst, A; Götze, R; Gröschel, M; Müller, S | 1 |
Adebola, SO; Adedeji, TO; Adefuye, BO; Oladeji, SM; Sogebi, OA | 1 |
Alffenaar, JW; Borjas Howard, JF; Dijkstra, JA; Kosterink, JG; van Altena, R; van der Meer, ME; van der Werf, TS; van Soolingen, D | 1 |
Cediel, R; Contreras, J; Murillo-Cuesta, S; Varela-Nieto, I | 1 |
Camarero, G; García-Alcántara, F; Murillo-Cuesta, S; Rivera, T; Sistiaga, JA; Vacas, E; Varela-Nieto, I | 1 |
Hirose, K; Ransohoff, RM; Sato, E; Shick, HE | 1 |
Agterberg, MJ; de Groot, JC; Grolman, W; Havenith, S; Klis, SF; Sedee, RJ; Versnel, H | 1 |
Hirose, K; Sato, E | 1 |
Chen, J; Chen, Q; Chu, H; Cui, Y; Huang, X; Li, J; Li, Z; Wang, Y; Xiong, H; Zhou, L; Zhou, X | 1 |
Chan, HC; Chung, YW; Jiang, XH; Tang, H; Tsang, LL; Wang, AM; Yu, L; Yu, MK; Zhang, XH; Zhou, Z | 1 |
Lai, CJ; Liu, Q; Tian, J; Wang, TF; Yu, HM; Zhang, ZC; Zhou, XY | 1 |
Ding, DL; Jiang, HY; Liu, H; Salvi, R; Sun, H; Wu, XW | 1 |
Lesniak, W; Schacht, J; Sha, SH; Wang, AM | 1 |
Campbell, K | 1 |
PARTSCH, CJ | 2 |
BONNEVILLE, J; WAYOFF, M | 1 |
BRUNELLE, P | 1 |
LEACH, W | 1 |
FROST, JO | 1 |
BECK, C; KRAHL, P | 1 |
BANGS, J; BANGS, T; STEPHENSON, W; TENGG, NE; YOW, MD | 1 |
BREUNINGER, H | 1 |
CHEW, W | 1 |
SCHINDEL, L | 1 |
TAMARI, I; ZONDEK, B | 1 |
DEGREEF, I | 1 |
HAWKINS, JE | 1 |
KRAHL, P | 1 |
OWADA, K; SHIDA, K; WAKAZAWA, T | 1 |
Doi, K; Kaneda, Y; Kubo, T; Mizuno, S; Morishita, R; Nakamura, T; Oshima, K; Shimamura, M; Tamai, K | 1 |
Jiang, H; Schacht, J; Sha, SH | 1 |
Asoh, S; Kashio, A; Ohta, S; Sakamoto, T; Suzukawa, K; Yamasoba, T | 1 |
Gu, ZP; Ke, XM; Liu, YH; Qin, Y; Xiao, SF | 1 |
Konishi, T; Mori, H | 1 |
Alexander, A; Bryant, GM; Cronin-Schreiber, R; Guth, PS; Norris, CH; Quine, DB | 1 |
Niemierko, J; Rutkowski, B | 1 |
Lietman, PS; Moore, RD; Smith, CR | 1 |
Britten, J; Caplan, E; deJongh, CA; Finley, RS; Fortner, CL; Newman, KA; Schimpff, SC; Wade, JC; Wiernik, PH | 1 |
Bock, GR; Miller, JJ; Moorjani, P; Yates, GK | 1 |
Borg, E; Engström, B | 1 |
Deshpande, G; Faden, H; Grossi, M | 1 |
Chen, ZH; She, WD | 1 |
Basile, AS; Berlin, C; Huang, JM; Skolnick, P; Webster, D; Xie, C | 1 |
Dooling, RJ; Manabe, K; Ryals, BM | 1 |
Alam, SA; Ikeda, K; Katori, Y; Kawase, T; Kikuchi, T; Takasaka, T; Watanabe, K | 1 |
Hawkins, JE; Johnson, LG; Moody, DB; Stebbins, WC | 1 |
Ikonen, S; Janas, M; Pesonen, T; Rahko, T | 1 |
Hashino, E; Sokabe, M | 1 |
Hoffman, DW; Jones, KL; Rybak, LP; Whitworth, CA | 1 |
Uziel, A | 1 |
Bredberg, G; Lindquist, NG; Lyttkens, L; Rask-Anderson, H; Wästerström, SA | 1 |
Kameyama, T; Nabeshima, T; Yamaguchi, K | 1 |
2 review(s) available for kanamycin a and Hearing Loss
Article | Year |
---|---|
[UNEXPECTED DRUG EFFECTS: KANAMYCIN].
Topics: Deafness; Drug Hypersensitivity; Hearing Disorders; Hearing Loss; Humans; Kanamycin; Kidney Diseases; Toxicology; Vestibule, Labyrinth | 1964 |
Non-genetic factors affecting hearing development.
Topics: Adult; Age Factors; Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Cochlea; Deafness; Female; Guinea Pigs; Hearing Loss; Hearing Loss, Noise-Induced; Humans; Hyperbilirubinemia; Hypothyroidism; Infant; Infant, Newborn; Kanamycin; Maternal-Fetal Exchange; Pregnancy; Rats | 1985 |
2 trial(s) available for kanamycin a and Hearing Loss
Article | Year |
---|---|
Risk factors for the development of auditory toxicity in patients receiving aminoglycosides.
Topics: Amikacin; Body Temperature; Female; Gentamicins; Hearing Loss; Humans; Kanamycin; Male; Probability; Risk; Sepsis; Statistics as Topic; Time Factors; Tobramycin | 1984 |
Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients.
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fever; Hearing Loss; Humans; Kanamycin; Kidney; Kinetics; Moxalactam; Neoplasms; Piperacillin; Ticarcillin | 1982 |
68 other study(ies) available for kanamycin a and Hearing Loss
Article | Year |
---|---|
Pravastatin Administration Alleviates Kanamycin-Induced Cochlear Injury and Hearing Loss.
Topics: Animals; Caspase 3; Cochlea; Deafness; Evoked Potentials, Auditory, Brain Stem; Hearing Loss; Kanamycin; Poly(ADP-ribose) Polymerase Inhibitors; Pravastatin; Rats | 2022 |
A reduced form of nicotinamide riboside protects the cochlea against aminoglycoside-induced ototoxicity by SIRT1 activation.
Topics: 14-3-3 Proteins; Aminoglycosides; Animals; Anti-Bacterial Agents; Cochlea; Hearing Loss; Kanamycin; Mice; NAD; Niacinamide; Ototoxicity; Pyridinium Compounds; Reactive Oxygen Species; Resveratrol; Sirtuin 1 | 2022 |
Oridonin alleviates kanamycin-related hearing loss by inhibiting NLRP3/caspase-1/gasdermin D-induced inflammasome activation and hair cell pyroptosis.
Topics: Animals; Caspase 1; Diterpenes, Kaurane; Hair; Hearing Loss; Inflammasomes; Interleukin-1beta; Kanamycin; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis; Reactive Oxygen Species | 2022 |
[Kanamycin-induced ototoxicity during treatment of multidrug-resistant tuberculosis].
Topics: Adult; Aminoglycosides; Antitubercular Agents; Cameroon; Female; Hearing Loss; Humans; Incidence; Kanamycin; Male; Ototoxicity; Retrospective Studies; Tuberculosis, Multidrug-Resistant | 2020 |
Prevalence of Pre-Existing Hearing Loss Among Patients With Drug-Resistant Tuberculosis in South Africa.
Topics: Adolescent; Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antitubercular Agents; Audiometry; Auditory Threshold; Cross-Sectional Studies; Female; Hearing Loss; HIV Infections; Humans; Hypoalbuminemia; Kanamycin; Male; Middle Aged; Ototoxicity; Prevalence; Renal Insufficiency; South Africa; Thinness; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
Generation of Cochlear Hair Cells from Sox2 Positive Supporting Cells via DNA Demethylation.
Topics: Animals; Azacitidine; DNA Methylation; Female; Furosemide; Hair Cells, Auditory; Hearing Loss; Kanamycin; Male; Mice; Mice, Transgenic; SOXB1 Transcription Factors | 2020 |
Characterization of EGR-1 Expression in the Auditory Cortex Following Kanamycin-Induced Hearing Loss in Mice.
Topics: Animals; Auditory Cortex; Cyclic AMP Response Element-Binding Protein; Dizocilpine Maleate; Early Growth Response Protein 1; Evoked Potentials, Auditory, Brain Stem; Excitatory Amino Acid Antagonists; Hearing Loss; Kanamycin; Mice; Mice, Inbred CBA; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt | 2021 |
SOD2 Alleviates Hearing Loss Induced by Noise and Kanamycin in Mitochondrial DNA4834-deficient Rats by Regulating PI3K/MAPK Signaling.
Topics: DNA, Mitochondrial; Gene Expression Regulation; Hearing Loss; Kanamycin; Mitochondria; Mitogen-Activated Protein Kinase Kinases; Noise; Phosphatidylinositol 3-Kinases; Signal Transduction; Superoxide Dismutase | 2021 |
The expression of oxidative stress response genes is modulated by a combination of resveratrol and N-acetylcysteine to ameliorate ototoxicity in the rat cochlea.
Topics: Acetylcysteine; Animals; Antioxidants; Apoptosis; Auditory Fatigue; Brain Stem; Cochlea; Cytoprotection; Disease Models, Animal; Drug Therapy, Combination; Evoked Potentials, Auditory, Brain Stem; Furosemide; Gene Expression Regulation; Hearing; Hearing Loss; Inflammation Mediators; Kanamycin; Male; Oxidative Stress; Rats, Wistar; Reaction Time; Resveratrol | 2018 |
Hearing loss with kanamycin treatment for multidrug-resistant tuberculosis in Bangladesh.
Topics: Adult; Aminoglycosides; Antitubercular Agents; Bangladesh; Body Mass Index; Cohort Studies; Female; Hearing Loss; Humans; Kanamycin; Kaplan-Meier Estimate; Male; Mycobacterium tuberculosis; Risk Factors; Tuberculosis, Multidrug-Resistant | 2018 |
The Novel Peptide Vaccine GV1001 Protects Hearing in a Kanamycin-induced Ototoxicity Mouse Model.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Ear, Inner; Hair Cells, Auditory; Hearing; Hearing Loss; Kanamycin; Male; Mice; Peptide Fragments; Telomerase; Vaccines, Subunit | 2018 |
Upregulation of HSP60 expression in the postnatal rat cochlea and rats with drug-induced hearing loss.
Topics: Animals; Auditory Threshold; Chaperonin 60; Cochlea; Evoked Potentials, Auditory, Brain Stem; Furosemide; Hair Cells, Auditory; Hearing Loss; Kanamycin; Labyrinth Supporting Cells; Mitochondrial Proteins; Rats; Rats, Sprague-Dawley; Spiral Ganglion; Transcriptional Activation; Up-Regulation | 2018 |
In vivo transcranial flavoprotein autofluorescence imaging of tonotopic map reorganization in the mouse auditory cortex with impaired auditory periphery.
Topics: Acoustic Stimulation; Animals; Auditory Cortex; Auditory Threshold; Brain Mapping; Bumetanide; Disease Models, Animal; Evoked Potentials, Auditory; Female; Flavoproteins; Hearing; Hearing Loss; Kanamycin; Mice, Inbred C57BL; Microscopy, Fluorescence; Neuronal Plasticity; Optical Imaging; Reaction Time; Time Factors | 2019 |
Generation of new hair cells by DNA methyltransferase (Dnmt) inhibitor 5-azacytidine in a chemically-deafened mouse model.
Topics: Animals; Azacitidine; Cochlea; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; Ear, Inner; Enzyme Inhibitors; Furosemide; Hair Cells, Auditory, Inner; Hearing Loss; Humans; Kanamycin; Mice; Regeneration | 2019 |
[Math1 gene therapy for kanamycin and furosemide-induced deaf guinea pigs].
Topics: Adenoviridae; Animals; Basic Helix-Loop-Helix Transcription Factors; Cochlea; Deafness; Ear, Inner; Evoked Potentials, Auditory, Brain Stem; Furosemide; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; Guinea Pigs; Hair Cells, Auditory; Hearing Loss; Kanamycin; Perilymph | 2013 |
Profile of adverse drug reactions in drug resistant tuberculosis from Punjab.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Arthralgia; Ataxia; Chemical and Drug Induced Liver Injury; Child; Cycloserine; Drug Eruptions; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Gastrointestinal Diseases; Hearing Loss; Humans; Hypothyroidism; India; Kanamycin; Levofloxacin; Male; Middle Aged; Peripheral Nervous System Diseases; Psychoses, Substance-Induced; Pyrazinamide; Severity of Illness Index; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vision Disorders; Young Adult | 2014 |
Aminoglycoside ototoxicity and hair cell ablation in the adult gerbil: A simple model to study hair cell loss and regeneration.
Topics: Aminoglycosides; Animals; Cochlea; Disease Models, Animal; Female; Gerbillinae; Hair Cells, Auditory, Outer; Hearing; Hearing Loss; Humans; Immunohistochemistry; Kanamycin; Male; Myelin Sheath; Phalloidine; Regeneration; Spiral Ganglion | 2015 |
Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Body Weight; Chi-Square Distribution; Child; Child, Preschool; Coinfection; Hearing Loss; Hearing Tests; HIV Infections; Humans; Incidence; Infant; Infant, Newborn; Kanamycin; Logistic Models; Middle Aged; Namibia; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Tuberculosis, Multidrug-Resistant | 2015 |
Cortical and thalamic connectivity of the auditory anterior ectosylvian cortex of early-deaf cats: Implications for neural mechanisms of crossmodal plasticity.
Topics: Acoustic Stimulation; Adaptation, Physiological; Age Factors; Animals; Auditory Cortex; Auditory Pathways; Auditory Perception; Cats; Disease Models, Animal; Hearing; Hearing Loss; Kanamycin; Neuroanatomical Tract-Tracing Techniques; Neuronal Plasticity; Photic Stimulation; Thalamus; Visual Cortex; Visual Perception | 2016 |
Central Nervous Activity upon Systemic Salicylate Application in Animals with Kanamycin-Induced Hearing Loss--A Manganese-Enhanced MRI (MEMRI) Study.
Topics: Amygdala; Animals; Auditory Cortex; Auditory Threshold; Cochlea; Female; Hearing Loss; Hypothalamus; Kanamycin; Magnetic Resonance Imaging; Male; Manganese; Mice; Radiography; Salicylates | 2016 |
Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant Tuberculosis patients on intensive therapy.
Topics: Adult; Age Factors; Aminoglycosides; Antitubercular Agents; Audiometry, Pure-Tone; Body Mass Index; Coinfection; Comorbidity; Cycloserine; Diabetes Mellitus; Female; Hearing Loss; HIV Infections; Humans; Kanamycin; Levofloxacin; Male; Middle Aged; Nigeria; Prospective Studies; Prothionamide; Pyrazinamide; Risk Factors; Time Factors; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis.
Topics: Adult; Amikacin; Antitubercular Agents; Area Under Curve; Audiometry; Biological Availability; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Extensively Drug-Resistant Tuberculosis; Female; Hearing Loss; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Retrospective Studies | 2017 |
Comparison of different aminoglycoside antibiotic treatments to refine ototoxicity studies in adult mice.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Cochlea; Disease Models, Animal; Dose-Response Relationship, Drug; Evoked Potentials, Auditory, Brain Stem; Gentamicins; Hearing Loss; Kanamycin; Male; Mice; Mice, Inbred C57BL; Mortality; Neomycin | 2010 |
Direct drug application to the round window: a comparative study of ototoxicity in rats.
Topics: Administration, Topical; Animals; Cochlea; Evoked Potentials, Auditory, Brain Stem; Furosemide; Hearing Loss; Injections, Intravenous; Injections, Subcutaneous; Kanamycin; Male; Random Allocation; Rats; Rats, Wistar; Round Window, Ear | 2009 |
Expression of fractalkine receptor CX3CR1 on cochlear macrophages influences survival of hair cells following ototoxic injury.
Topics: Animals; Auditory Threshold; Bone Marrow; Cell Survival; Cochlea; CX3C Chemokine Receptor 1; Evoked Potentials, Auditory, Brain Stem; Female; Hair Cells, Auditory, Outer; Hearing Loss; Kanamycin; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pregnancy; Protein Synthesis Inhibitors; Radiation Chimera; Receptors, Chemokine | 2010 |
Spiral ganglion cell survival after round window membrane application of brain-derived neurotrophic factor using gelfoam as carrier.
Topics: Acoustic Stimulation; Animals; Auditory Threshold; Brain-Derived Neurotrophic Factor; Cell Shape; Cell Size; Cell Survival; Disease Models, Animal; Drug Carriers; Electric Stimulation; Evoked Potentials, Auditory, Brain Stem; Female; Furosemide; Gelatin Sponge, Absorbable; Guinea Pigs; Hearing Loss; Kanamycin; Neuroprotective Agents; Spiral Ganglion; Time Factors | 2011 |
Comparative analysis of combination kanamycin-furosemide versus kanamycin alone in the mouse cochlea.
Topics: Acoustic Stimulation; Animals; Atrophy; Auditory Threshold; Cell Death; Cell Movement; Cochlea; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Furosemide; Hair Cells, Auditory, Outer; Hearing Loss; Kanamycin; Macrophages; Male; Mice; Mice, Inbred C57BL; Monocytes | 2011 |
Conservation of endocochlear potential in mice with profound hearing loss induced by co-administration of kanamycin and furosemide.
Topics: Animals; Anti-Bacterial Agents; Auditory Threshold; Cell Death; Cell Survival; Cochlea; Cochlear Microphonic Potentials; Disease Models, Animal; Diuretics; Drug Combinations; Evoked Potentials, Auditory, Brain Stem; Furosemide; Hair Cells, Auditory, Inner; Hair Cells, Auditory, Outer; Hearing Loss; Kanamycin; Male; Mice; Mice, Inbred CBA; Protein Synthesis Inhibitors; Stria Vascularis; Time Factors | 2011 |
A protective mechanism against antibiotic-induced ototoxicity: role of prestin.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Cell Line; CHO Cells; Cricetinae; Cricetulus; Cytoprotection; Ear Diseases; Hair Cells, Auditory; Hearing Loss; Kanamycin; Male; Mice; Mice, Inbred BALB C; Molecular Motor Proteins | 2011 |
[Ototoxicity of kanamycin sulfate in adult rats and its underlying mechanisms].
Topics: Animals; Cochlea; Evoked Potentials, Auditory, Brain Stem; Hair Cells, Auditory, Outer; Hearing Loss; Kanamycin; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Spiral Ganglion | 2011 |
Ototoxic destruction by co-administration of kanamycin and ethacrynic acid in rats.
Topics: Animals; Anti-Bacterial Agents; Deafness; Ear, Inner; Ethacrynic Acid; Hearing Loss; Kanamycin; Rats; Rats, Sprague-Dawley; Stria Vascularis | 2011 |
Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminoglycoside-induced free radical formation in vitro and ototoxicity in vivo.
Topics: Abietanes; Animals; Anti-Bacterial Agents; Auditory Threshold; Cochlea; Drug Interactions; Drugs, Chinese Herbal; Evoked Potentials, Auditory, Brain Stem; Free Radical Scavengers; Gentamicins; Hearing Loss; Hydroxyl Radical; Kanamycin; Lipid Peroxidation; Male; Mice; Mice, Inbred CBA; Oxidants; Phenanthrenes; Superoxides | 2003 |
A milligram of prevention.
Topics: Anti-Bacterial Agents; Hearing Loss; Hearing Loss, Noise-Induced; Humans; Kanamycin | 2003 |
[Audiological tests in kanamycin therapy].
Topics: Anti-Bacterial Agents; Audiology; Audiometry; Deafness; Hearing Loss; Humans; Kanamycin | 1961 |
[Nil nocere: On the ototoxicity of kanamycin].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Deafness; Ear Diseases; Hearing Loss; Kanamycin | 1961 |
[2 cases of deafness caused by kanamycin].
Topics: Anti-Bacterial Agents; Deafness; Hearing Loss; Kanamycin | 1960 |
The toxic effect of kanamycin on the inner ear: report of a case.
Topics: Deafness; Ear, Inner; Hearing Loss; Kanamycin | 1959 |
Ototoxicity of neomycin and other antibiotics.
Topics: Anti-Bacterial Agents; Deafness; Ear; Hearing Loss; Kanamycin; Neomycin; Polymyxins; Ristocetin; Streptomycin; Vancomycin; Viomycin | 1962 |
The problem of ototoxicity in the treatment of tuberculosis.
Topics: Deafness; Dihydrostreptomycin Sulfate; Ear, Inner; Hearing Loss; Humans; Kanamycin; Kidney Diseases; Neomycin; Streptomycin; Tuberculosis; Viomycin | 1963 |
[Experimental and fine tissue studies on the ototoxicity of kanamycin].
Topics: Cochlea; Deafness; Ear, Inner; Hearing Loss; Kanamycin | 1962 |
The ototoxic effects of kanamycin sulfate in infants and children.
Topics: Craniocerebral Trauma; Deafness; Ear, Inner; Hearing Loss; Kanamycin | 1962 |
[Bilateral deafness after instillation treatment of a preumonectomy cavity with neomycin and kanamycin].
Topics: Deafness; Hearing Loss; Humans; Kanamycin; Neomycin; Pneumonectomy | 1963 |
THE CHANGING ROLE OF THE OTOLARYNGOLOGIST IN TUBERCULOSIS: EVALUATION OF ANTIBIOTICS IN HEARING IMPAIRMENT.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Hearing Disorders; Hearing Loss; Kanamycin; Neomycin; Pantothenic Acid; Streptomycin; Toxicology; Tuberculosis; Viomycin | 1964 |
EFFECT OF AUDITORY STIMULATION OF REPRODUCTION. IV. EXPERIMENTS OF DEAF RATS.
Topics: Acoustic Stimulation; Cochlea; Deafness; Fertility; Hearing Loss; Kanamycin; Pharmacology; Rats; Research; Toxicology | 1964 |
THE OTOTOXICITY OF KANAMYCIN. A THEORETICAL AND EXPERIMENTAL STUDY.
Topics: Cats; Chemical Phenomena; Chemistry; Cochlea; Deafness; Dihydrostreptomycin Sulfate; Ear, Inner; Guinea Pigs; Hearing Loss; Kanamycin; Kidney; Neomycin; Pathology; Pharmacology; Research; Streptomycin; Tinnitus; Toxicology; Viomycin | 1964 |
The ototoxicity of kanamycin.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Deafness; Ear, Inner; Hearing Loss; Kanamycin | 1959 |
[Experimental research on the ototoxicity of kanamycin and the possibilities of its prevention].
Topics: Ascorbic Acid; Deafness; Ear Diseases; Hearing Loss; Kanamycin | 1962 |
[Study of the prevention of kanamycin ototoxity].
Topics: Biomedical Research; Deafness; Hearing Loss; Humans; Kanamycin | 1962 |
Intrathecal injection of HVJ-E containing HGF gene to cerebrospinal fluid can prevent and ameliorate hearing impairment in rats.
Topics: Animals; Cerebrospinal Fluid; Ear, Inner; Genetic Therapy; Genetic Vectors; Hearing Loss; Hepatocyte Growth Factor; Injections, Spinal; Kanamycin; Rats; Sendai virus; Subarachnoid Space; Transfection | 2004 |
Kanamycin alters cytoplasmic and nuclear phosphoinositide signaling in the organ of Corti in vivo.
Topics: Animals; Cell Nucleus; Cytoplasm; Hair Cells, Auditory, Outer; Hearing Loss; Kanamycin; Male; Mice; Mice, Inbred CBA; Organ of Corti; Phosphatidylinositols | 2006 |
A protein derived from the fusion of TAT peptide and FNK, a Bcl-x(L) derivative, prevents cochlear hair cell death from aminoglycoside ototoxicity in vivo.
Topics: Aminoglycosides; Analysis of Variance; Animals; bcl-X Protein; Cell Death; Cochlea; Ethacrynic Acid; Evoked Potentials, Auditory, Brain Stem; Gene Products, tat; Guinea Pigs; Hair Cells, Auditory; Hearing Loss; Immunohistochemistry; Kanamycin; Male; Neuroprotective Agents; Peptide Fragments; Recombinant Fusion Proteins | 2007 |
Adeno-associated virus-mediated Bcl-xL prevents aminoglycoside-induced hearing loss in mice.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; bcl-X Protein; Cochlea; Dependovirus; Female; Genetic Therapy; Hearing Loss; Kanamycin; Mice; Mice, Inbred C57BL | 2007 |
Permeability to sodium ions of the endolymph-perilymph barrier.
Topics: Action Potentials; Animals; Cell Membrane Permeability; Cochlear Microphonic Potentials; Electric Conductivity; Endolymph; Guinea Pigs; Hearing Loss; Hearing Loss, Noise-Induced; Hypoxia; Kanamycin; Labyrinthine Fluids; Membrane Potentials; Perilymph; Sodium | 1984 |
The potentiation of ototoxicity when aminooxyacetic acid and kanamycin are co-administered.
Topics: Acetates; Aminooxyacetic Acid; Animals; Cochlea; Cochlear Microphonic Potentials; Drug Synergism; Guinea Pigs; Hair Cells, Auditory; Hearing Loss; Kanamycin; Time Factors | 1984 |
[Amikacin-induced hearing loss in patients treated with repeated hemodialysis].
Topics: Adult; Amikacin; Endocarditis, Bacterial; Female; Hearing Loss; Hearing Loss, Bilateral; Humans; Kanamycin; Kidney Failure, Chronic; Male; Middle Aged; Pneumonia; Renal Dialysis | 1984 |
Effects of N-acetylcysteine on kanamycin ototoxicity in the guinea pig.
Topics: Acetylcysteine; Action Potentials; Animals; Drug Synergism; Free Radicals; Guinea Pigs; Hair Cells, Auditory; Hearing; Hearing Loss; Kanamycin | 1983 |
Acoustic reflex after experimental lesions to inner and outer hair cells.
Topics: Animals; Auditory Threshold; Hair Cells, Auditory; Hair Cells, Auditory, Inner; Hearing Loss; Hearing Loss, Noise-Induced; Kanamycin; Rabbits; Reflex, Acoustic | 1982 |
Renal and Auditory toxic effects of amikacin in children with cancer.
Topics: Adolescent; Amikacin; Bacterial Infections; Child; Child, Preschool; Hearing Loss; Hearing Loss, High-Frequency; Humans; Infant; Kanamycin; Kidney Diseases; Neoplasms | 1982 |
[Effect of ligustrazine on kanamycin ototoxicity].
Topics: Animals; Auditory Threshold; Cochlea; Female; Free Radical Scavengers; Guinea Pigs; Hearing Loss; Kanamycin; Male; Malondialdehyde; Pyrazines; Superoxide Dismutase | 1995 |
N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss.
Topics: Animals; Anti-Bacterial Agents; Cochlea; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Guinea Pigs; Hair Cells, Auditory; Hearing Loss; Hearing Tests; Kanamycin; Male; N-Methylaspartate; Neomycin; Piperidines; Prosencephalon; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1996 |
Recovery of hearing and vocal behavior after hair-cell regeneration.
Topics: Animals; Auditory Perception; Auditory Threshold; Conditioning, Psychological; Discrimination, Psychological; Hair Cells, Auditory; Hearing; Hearing Loss; Humans; Kanamycin; Learning; Male; Parakeets; Regeneration; Time Factors; Vocalization, Animal | 1997 |
Acute effects of combined administration of kanamycin and furosemide on the stria vascularis studied by distortion product otoacoustic emission and transmission electron microscopy.
Topics: Animals; Anti-Bacterial Agents; Diuretics; Drug Synergism; Furosemide; Guinea Pigs; Hearing Loss; Kanamycin; Microscopy, Electron; Otoacoustic Emissions, Spontaneous; Stria Vascularis | 1998 |
Hearing thresholds with outer and inner hair cell loss.
Topics: Animals; Audiometry; Auditory Threshold; Cell Count; Dihydrostreptomycin Sulfate; Erythrocebus patas; Guinea Pigs; Hair Cells, Auditory; Hair Cells, Auditory, Inner; Hearing Loss; Hearing Loss, Noise-Induced; Kanamycin; Macaca; Neomycin | 1979 |
Results of hearing testing at 7-year follow-up of kanamycin-treated newborn infants.
Topics: Audiometry; Bacterial Infections; Child; Female; Follow-Up Studies; Hearing; Hearing Loss; Hearing Tests; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kanamycin; Male | 1978 |
Kanamycin induced low-frequency hearing loss in the budgerigar (Melopsittacus undulatus).
Topics: Animals; Audiometry; Auditory Fatigue; Auditory Threshold; Dose-Response Relationship, Drug; Hearing Loss; Kanamycin; Male; Parakeets; Psittaciformes | 1989 |
Nutritional status, glutathione levels, and ototoxicity of loop diuretics and aminoglycoside antibiotics.
Topics: Animals; Chinchilla; Cochlea; Deafness; Drug Synergism; Ethacrynic Acid; Evoked Potentials, Auditory; Food Deprivation; Glutathione; Hearing Loss; Inactivation, Metabolic; Kanamycin; Liver; Nutritional Status | 1987 |
Ototoxicity of kanamycin in albino and pigmented guinea pigs. I. A morphologic and electrophysiologic study.
Topics: Animals; Audiometry, Evoked Response; Guinea Pigs; Hair Cells, Auditory; Hair Cells, Auditory, Inner; Hearing Loss; Kanamycin; Male; Melanins | 1986 |
[Measurement of an auditory impairment induced by aminoglycosides using a shuttle box method in newborn rats].
Topics: Animals; Animals, Newborn; Auditory Threshold; Avoidance Learning; Conditioning, Classical; Female; Hearing Loss; Hearing Tests; Kanamycin; Male; Rats; Rats, Inbred Strains; Streptomycin; Toxicology | 1985 |